Saturday 17 October 2026
Export AVTR’s income statement to Excel — free account
Avantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 33.3%, free cash flow grew 12.7% and total debt fell 12.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
16.42
0.33
+2.05%
Follow AVTR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 6 | 5 | 6 | 5 | 7 | — | — | — | — |
P/E ratio |
0.00 | 20.07 | 47.40 | 20.55 | 49.00 | 312.78 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.19 | 2.11 | 2.21 | 1.83 | 3.37 | 2.54 | 1.21 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
1.55 | 2.52 | 2.16 | 2.00 | 2.44 | 2.33 | 1.49 | — | — | — |
Altman Z″-Score (non-manufacturers) |
1.86 | 2.29 | 1.91 | 1.93 | 1.52 | 1.49 | 1.30 | 0.49 | — | 1.08 |
P/FCF ratio |
15.76 | 20.69 | 21.24 | 19.40 | 29.54 | 18.69 | 24.08 | 8.54 | 8.54 | 8.54 |
P/Operating CF |
51.08 | 82.63 | 61.09 | 67.02 | 82.67 | 53.02 | 83.70 | 25.67 | 25.67 | 25.67 |
Beneish M-Score |
(2.91) | (2.58) | (2.70) | (2.53) | (2.47) | (2.76) | (2.52) | — | — | — |
P/B ratio |
1.40 | 2.40 | 2.93 | 2.84 | 7.79 | 9.71 | 4.99 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.74 | 2.67 | 2.96 | 2.62 | 4.28 | 3.26 | 2.02 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
65.97 | 12.06 | 18.57 | 12.69 | 23.11 | 18.51 | 12.41 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
18.24 | 21.54 | 23.73 | 23.35 | 33.14 | 22.40 | 34.50 | 31.45 | 31.45 | 31.45 |
EV/FCF |
22.99 | 26.18 | 28.53 | 27.73 | 37.51 | 23.99 | 40.38 | 38.45 | 38.45 | 38.45 |
Quick Ratio |
1.04 | 0.65 | 0.95 | 0.96 | 1.05 | 1.13 | 1.09 | 1.02 | 0.96 | 1.11 |
Current Ratio |
1.78 | 1.07 | 1.61 | 1.60 | 1.71 | 1.80 | 1.88 | 1.73 | 1.66 | 2.15 |
Net Debt/EBITDA |
20.76 | 2.53 | 4.74 | 3.81 | 4.91 | 4.09 | 5.01 | 7.84 | (69.68) | 12.58 |
Debt/Assets |
33.46% | 33.48% | 42.68% | 46.70% | 50.54% | 49.40% | 52.35% | 69.86% | 0.00% | 114.08% |
Debt/Equity |
0.71 | 0.68 | 1.05 | 1.29 | 1.67 | 1.83 | 2.08 | (2.27) | 0.00 | (3.46) |
Asset Turnover |
0.55 | 0.54 | 0.53 | 0.55 | 0.62 | 0.65 | 0.61 | 1.06 | 2.20 | 0.12 |
Operating CF/Net income |
(1.18) | 1.18 | 2.71 | 1.27 | 1.88 | 17.88 | (1.06) | (0.56) | 1.49 | (1.74) |
Capex/Depreciation |
(0.31) | (0.36) | (0.35) | (0.32) | (0.28) | (0.15) | (0.12) | (0.08) | (0.23) | 0.00 |
Interest Coverage |
(1.45) | 4.96 | 2.45 | 4.25 | 4.47 | 2.30 | 1.25 | 0.79 | (1.05) | 0.69 |
| (9.20%) | 12.69% | 6.35% | 16.46% | 20.89% | 3.32% | 42.07% | 12.57% | 7.53% | 2.80% | |
| (4.44%) | 5.67% | 2.43% | 4.84% | 4.27% | 0.53% | (3.40%) | (6.45%) | (19.84%) | (0.73%) | |
ROIC |
(1.68%) | 6.95% | 4.13% | 6.56% | 5.57% | 6.07% | 4.67% | 7.01% | (1.90%) | 0.00% |
Return on Tangible Assets |
(28.83%) | 83.98% | 19.55% | 38.37% | 29.33% | 3.38% | (22.28%) | (25.42%) | (8.08%) | (11.67%) |
Average Days of Receivables |
59.86 | 55.66 | 60.26 | 59.20 | 60.39 | 63.56 | 59.75 | 57.96 | 256.03 | 46.48 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
24.35% | 24.19% | 21.62% | 19.60% | 20.72% | 21.49% | 22.66% | 23.96% | 36.05% | 40.96% |
Intangible Assets out of Total Assets |
0.69 | 0.73 | 0.73 | 0.73 | 0.75 | 0.70 | 0.72 | 0.74 | 0.00 | 0.55 |
Share Based Compensation of Revenue |
0.71% | 0.69% | 0.58% | 0.61% | 0.69% | 0.69% | 1.12% | 0.31% | 3.86% | 0.00% |
Graham Net Nets |
(0.48) | (0.28) | (0.35) | (0.43) | (0.29) | (0.31) | (0.73) | 0.99 | 0.99 | 0.99 |
Graham Number |
0.00 | 14.39 | 9.16 | 13.15 | 10.23 | 2.42 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(6.81%) | 4.98% | 2.11% | 4.87% | 2.04% | 0.32% | (5.05%) | (10.55%) | (10.55%) | (10.55%) |
Free Cash Flow Yield |
6.35% | 4.83% | 4.71% | 5.15% | 3.39% | 5.35% | 4.15% | 11.71% | 11.71% | 11.71% |
Revenue per Share |
9.63 | 9.98 | 10.31 | 11.54 | 12.51 | 11.09 | 15.06 | 44.19 | 8.26 | 1.29 |
Operating CF per Share |
0.92 | 1.24 | 1.29 | 1.30 | 1.61 | 1.61 | 0.88 | 1.51 | (1.11) | 0.14 |
Capex per Share |
(0.19) | (0.22) | (0.22) | (0.20) | (0.19) | (0.11) | (0.13) | (0.28) | (0.17) | 0.00 |
Free Cash Flow per Share |
0.73 | 1.02 | 1.07 | 1.09 | 1.43 | 1.51 | 0.75 | 1.23 | (1.28) | 0.14 |
Cash per Share |
0.54 | 0.39 | 0.39 | 0.57 | 0.51 | 0.50 | 0.47 | 1.39 | 1.22 | 0.12 |
Shareholders Equity per Share |
8.18 | 8.77 | 7.77 | 7.46 | 7.11 | 4.64 | 6.14 | (23.00) | 0.00 | (0.70) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.18 | 8.77 | 7.77 | 7.46 | 7.11 | 4.64 | 6.14 | (23.00) | 0.00 | (0.70) |
Free Cash Flow |
495.00 | 692.00 | 723.60 | 710.20 | 842.50 | 868.20 | 302.40 | 162.80 | (192.70) | 72.90 |
Working Capital |
1,072.30 | 139.10 | 904.60 | 999.10 | 1,026.40 | 988.20 | 947.00 | 803.40 | 730.00 | 156.00 |
Capital Expenditures |
(128.80) | (148.80) | (146.40) | (133.40) | (111.10) | (61.60) | (51.60) | (37.70) | (25.20) | (29.90) |
Net Current Asset Value |
(3,778.50) | (4,011.20) | (5,335.20) | (5,951.00) | (7,223.00) | (5,001.30) | (5,289.60) | (11,063.70) | 1,834.00 | (1,354.00) |
EV/EBIT |
0.00 | 16.70 | 29.64 | 17.43 | 32.51 | 29.47 | 22.13 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 |
Price to Operating Income |
0.00 | 13.20 | 22.07 | 12.19 | 25.60 | 22.95 | 13.20 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.55 | 0.59 | 0.56 | 0.58 | 0.56 | 0.76 | 0.78 | 0.75 | 0.17 | 0.30 |
Cash ROIC |
5.01% | 6.74% | 6.55% | 6.17% | 7.31% | 11.05% | 3.89% | 4.01% | (2.64%) | 7.41% |
Accounts Receivable Turnover |
6.21 | 6.21 | 5.88 | 6.16 | 6.33 | 6.08 | 6.29 | 6.49 | 2.59 | 1.44 |
Accounts Payable Turnover |
6.28 | 6.99 | 6.65 | 6.49 | 6.81 | 6.96 | 7.37 | 7.36 | 2.76 | 1.26 |
Inventory Turnover |
5.70 | 5.78 | 5.29 | 5.50 | 6.06 | 5.95 | 5.96 | 5.92 | 1.99 | 0.91 |
Average Days of Payables |
61.35 | 53.71 | 49.63 | 56.37 | 56.44 | 57.45 | 49.63 | 50.30 | 242.86 | 47.10 |
Days of Inventory on Hand |
67.68 | 59.28 | 65.66 | 67.91 | 65.18 | 62.59 | 63.01 | 60.56 | 311.41 | 119.70 |
Average Receivables |
1,054.55 | 1,092.35 | 1,184.30 | 1,220.25 | 1,167.70 | 1,051.05 | 960.00 | 903.10 | 481.50 | 481.50 |
Average Payables |
702.25 | 644.35 | 692.05 | 756.65 | 717.00 | 619.55 | 558.80 | 549.70 | 295.00 | 295.00 |
Average Inventory |
774.85 | 779.80 | 870.80 | 892.75 | 805.80 | 725.40 | 691.15 | 683.05 | 408.50 | 408.50 |
Average Assets |
11,954.60 | 12,543.60 | 13,218.50 | 13,680.75 | 11,901.85 | 9,839.90 | 9,842.45 | 5,523.80 | 568.00 | 5,791.50 |
Average Common Equity |
5,760.85 | 5,604.65 | 5,054.00 | 4,024.35 | 2,431.95 | 1,564.55 | (796.60) | (2,835.85) | (1,497.50) | (1,497.50) |
Columns are period end dates